Recent developments in the clinical assessment of the metabolism of aromatics by high-performance, reversed-phase chromatography with amperometric detection.
High-performance liquid chromatography with electrochemical detection has developed into a tool with excellent capability to monitor picomole amounts of individual metabolites in both tissue and body-fluid specimens. Significant technical advances in the area of microparticle chemically-bonded stationary phases have led to dramatic improvements in both sensitivity and resolution. Reversed-phase systems can be modified to include charged exchange sites by addition of detergents to the mobile phase. Adjustment of the surface charge in this manner permits capacity factors for ionic sample components to be increased or decreased. This concept is quite compatible with electrochemical detection and has provided the foundation for several clinical assays now in routine use. Examples of additional applications are presented for the determination of catecholamines in tissue, 3-methoxy-4-hydroxyphenylglycol in urine, and dopamine-beta-hydroxylase activity in human serum.
D000818:Animals; D002394:Catechol O-Methyltransferase / Q000032:analysis; D002395:Catecholamines / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D003124:Colorimetry; D004296:Dopa Decarboxylase / Q000032:analysis; D004299:Dopamine beta-Hydroxylase / Q000032:analysis; D006801:Humans; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis; D014642:Vanilmandelic Acid / Q000032:analysis
D002395:Catecholamines; D014642:Vanilmandelic Acid; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D002394:Catechol O-Methyltransferase; D004296:Dopa Decarboxylase